Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
6 June 2022 |
Main ID: |
NCT03137550 |
Date of registration:
|
28/04/2017 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Combined Use of Multiple Biomarkers With Stress Testing to Detect Coronary Artery Disease
COMBAT-CAD |
Scientific title:
|
Combined Use of Multiple Biomarkers With Stress Testing to Detect Coronary Artery Disease |
Date of first enrolment:
|
April 12, 2017 |
Target sample size:
|
850 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03137550 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Germany
| | | | | | | |
Contacts
|
Name:
|
Stefan Blankenberg, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Head of the Department |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. Every patient referred to coronary angiography, or diagnostic work-up with suspicion of
CAD or progress of CAD (in case of CABG patients or already treated with PCI)
Exclusion Criteria:
1. Insufficient knowledge of the German language (able to understand and write the German
language)
2. Physical or psychological incapability to take part in the investigation
3. Persons with no sufficient language ability in German to understand the provided study
information material.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Coronary Artery Disease
|
Primary Outcome(s)
|
Diagnosis of coronary artery disease
[Time Frame: Within the initial diagnostic evaluation process (maximum within 30 days)]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|